drugset / Trial / NCT01936285
Colchicine in ST-elevation Myocardial Infarction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
* There is evidence that inflammatory processes may play detrimental role during the acute phase of myocardial infarction * The hypothesis of this study is that colchicine, by its anti-inflammatory action, may lead to reduction in infarct size, when administered during the acute phase of myocardial infarction
Timeline
- Start
- 2013-07
- Primary completion
- 2015-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colchicine | Small molecule | 0.5 mg | — |